During the past decade, Centrum Leczenia Padaczki i Migreny conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Leczenia Padaczki i Migreny" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Leczenia Padaczki i Migreny" are "Epilepsy" (1 trials), "Episodic Migraine" (1 trials), "Partial Epilepsy" (1 trials), "Primary Generalized Epilepsy" (1 trials) and "Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy" (1 trials). Many other conditions were trialed in "Centrum Leczenia Padaczki i Migreny" in a lesser frequency.

Most popular intervention types in "Centrum Leczenia Padaczki i Migreny" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Cenobamate" (2 trials), "Placebo" (2 trials), "AMG334" (1 trials), "Eslicarbazepine Acetate" (1 trials) and "Oral Prophylactic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Leczenia Padaczki i Migreny" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Leczenia Padaczki i Migreny". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Centrum Leczenia Padaczki i Migreny, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Leczenia Padaczki i Migreny, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".